Treatment with LA lowered renal CD4+ T cell percentages (SLE-vehicle: 2.7 ± 0.65 vs. SLE-LA: 1.3 ± 0.2%, P=0.02). This evidence concerns the gene CD4 and systemic lupus erythematosus.